noobmade.blogg.se

have been described in association with the use of very high doses, but their clinical significance is uncertain.” 1Ī 2002 Psychiatric Times article alerted the readership to new studies on marijuana withdrawal and called for additional research and reconsideration of the status of a cannabis withdrawal disorder. DSM-IV-TR clearly stated the reason for the omission: “Symptoms of possible cannabis withdrawal. All rights reserved.DSM-IV, published in 1994, did not include a cannabis withdrawal disorder diagnosis. However, they remain an interesting mediation, encouraging a patient's awareness and commitment to care.ĬUDIT-R Cannabis Cannabis use disorder Screening tools Trouble de l’usage du cannabis Outils de repérage CUDIT-R.Ĭopyright © 2020 L'Encéphale, Paris. These questionnaires are obviously not a substitute for a clinical diagnosis and must be followed by a specialist's evaluation. The CUDIT-R has good psychometric characteristics, is simple to use, and has been validated according to the criteria of DSM-5. The CUDIT-R is currently the only one to be validated based on DSM-5 diagnostic criteria.Īmong the many questionnaires available, few are suited for daily clinical practice in France because of their complexity, their long duration or the absence of a validated French translation. It is relevant that tools used for screening take into account these new diagnostic concepts. In the DSM-5, diagnoses of abuse or addiction have been grouped into a single diagnosis of cannabis use disorders with different levels of severity. Only the CAST has been validated in French, and the CUDIT-R is currently being validated. The CAGE-cannabis, the CAST, the CUDIT and its revised version the CUDIT-R, the PUM and the SDS are the only ones that have good characteristics for a short screening tool adapted to daily clinical practice, namely to be brief (fewer than 10 questions) and quick handover (less than 10minutes). Sixteen questionnaires were found according to the inclusion criteria. We conducted a narrative literature review on cannabis use assessment tools on PubMed and selected cannabis-specific questionnaires, validated for adolescent and/or adult populations, from scientific articles in English or French between 19.

Standardized questionnaires based on patient self-reporting are recognized as the best option for identifying cannabis use disorders because of their reliability and simplicity.

Early identification and appropriate care of cannabis use disorders thus constitute a major public health issue. Electronic address: use is widespread in France, particularly among adolescents and young adults, and can induce severe somatic, psychiatric and social consequences.

7 Université de Lorraine, Faculté de médecine, 54000 Nancy, France Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France Inserm U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France.Electronic address: 1 Université de Lorraine, Faculté de médecine, 54000 Nancy, France. 6 Service Universitaire d'Addictologie de Lyon (SUAL), Pôle MOPHA, 69500, Bron, CH Le Vinatier, France Université de Lyon UCBL INSERM U1028 CNRS UMR5292, Centre de Recherche en Neuroscience de Lyon (CRNL), 69678, Bron, France.5 Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.4 Service Universitaire d'Addictologie de Lyon (SUAL), Pôle MOPHA, 69500, Bron, CH Le Vinatier, France.3 Université de Lorraine, Faculté de médecine, 54000 Nancy, France Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France Inserm U1114, Fédération de Médecine Translationnelle de Strasbourg, Département de Psychiatrie, Centre Hospitalier Régional Universitaire de Strasbourg, Strasbourg, France.2 Pôle Hospitalo-Universitaire de Psychiatrie d'Adultes et d'Addictologie du Grand Nancy, Centre Psychothérapique de Nancy, Laxou, France.1 Université de Lorraine, Faculté de médecine, 54000 Nancy, France.